Cargando…
Treatment of Osteoporosis with Antiresoptive agent, Alendronate - warrants careful follow-up
INTRODUCTION: Alendronate is the most popular bisphosphonate used to prevent fragility fracture of postmenopausal osteoporosis. There is common belief among physicians that Alendronates are very safe without many side effects and they continue it for long time. Recent papers have shown that, some pa...
Autores principales: | Jain, Sumit Kumar, Roy, Shuvendu Prosad, Nagi, Onkar Nath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Indian Orthopaedic Research Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701117/ https://www.ncbi.nlm.nih.gov/pubmed/27298837 |
Ejemplares similares
-
Excised Femoral Heads in Hip Fracture Patients: Is Osteoporosis Worse Than Cancer?
por: Salar, Omer, et al.
Publicado: (2019) -
Alendronate Sodium in the Management of Osteoporosis
por: Prinsloo, P J J, et al.
Publicado: (2006) -
Esthetic Rehabilitation of a Young Patient With Immediately Loaded Single-Piece Basal Implants Following a Trauma Involving the Anterior Maxilla: Case Report With Five-Year Follow-Up
por: R, Shakir Ahmed, et al.
Publicado: (2023) -
Complications and Outcomes of the Internal Fixation of Non-displaced Femoral Neck Fracture in Old Patients: A Two-Year Follow-Up
por: Abdallatif, Ahmad G, et al.
Publicado: (2023) -
Five-year follow-up results of the PROFHER
trial comparing operative and non-operative treatment of adults
with a displaced fracture of the proximal humerus
por: Handoll, H. H., et al.
Publicado: (2017)